帝國製薬株式会社

Text Size
  • M
  • L

Language

  • JP
  • EN
  • About TEIKOKU SEIYAKU

    About TEIKOKU SEIYAKU

    • VISION2031
    • Patch Medication, Globally
    • For a World Without Pain
    • Hydrohesive®
    • A Familiar Company, Teikoku Seiyaku
    • International Focus
    • Plant
    • Laboratory
    • Teikoku Seiyaku Group
    • Locations
  • Company

    Company

    • Message
    • Corporate Philosophy
    • Company Overview
    • Office Locations
    • History

Contact us

News release

  • HOME
  • NEWS
  • 2016.10.4
    Execution of Basic Agreement for Sales Anti-Allergy Agent, Rupatadine Tablets

New Topics

  • Change in The Board of Directors
  • President and CEO Misako Fujioka In...
  • Change in The Board of Directors
  • Notice of Launch of ALLYDONE® Patch...
  • Manufacturing and Marketing Approva...
  • Execution of a license agreement on...
  • TEIKOKU SEIYAKU was selected as A G...
  • Change in The Board of Directors
  • Notice Launch of Rupafin® tablets i...
  • Notice regarding acquisition of man...

Backnumber

  • 2025
  • 2023
  • 2022
  • 2020
  • 2017
  • 2016
Page Top
  • 567 Sanbonmatsu, Higashikagawa, Kagawa 769-2695, Japan
  • TEL +81-879-25-2221
Contact us
  • Privacy(Japanese)
  • Sitemap

© 2024 Teikoku Seiyaku Co.,Ltd.

About TEIKOKU SEIYAKU
  • VISION2031
  • Patch Medication, Globally
  • For a World Without Pain
  • Hydrohesive®
  • A Familiar Company, Teikoku Seiyaku
  • International Focus
  • Plant
  • Laboratory
  • Teikoku Seiyaku Group
  • Locations
Company
  • Message
  • Corporate Philosophy
  • Company Overview
  • Office Locations
  • History
News release